A family of localized immunotherapies.
Pipeline
One day, all solid cancers will be managed with dose-unlimited, localized immunotherapy.
Starting with breast and head & neck cancers, built for every solid tumor.
XCSgel can be paired with different immunotherapies and injected into tumors throughout the body. Our lead program, IT-001, targets triple-negative breast cancer and head and neck cancers.
Veterinary Studies
Treating pets with naturally-occurring cancers
Cancers that arise naturally in dogs and horses closely resemble human disease. In collaboration with the NC State College of Veterinary Medicine, these studies help pets and generate data to guide clinical development.
Canine
Soft-tissue sarcoma
IT-001 is being evaluated in pet dogs with soft-tissue sarcoma, including whether it can enhance the effect of radiation therapy.
Canine
Melanoma
Assessing whether IT-001 can strengthen irreversible electroporation, a minimally invasive tumor ablation technique, in dogs with melanoma.
Equine
Melanoma
Evaluating IT-001 in horses with melanoma, a common cancer in gray horses that often forms multiple injectable tumors.